Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

United States

Cedars Sinai Medical Center, Los Angeles, California

Northwestern Memorial Hospital, Chicago, Illinois

Kansas University Medical Center, Kansas City, Kansas

Montefiore Medical Center, The Bronx, New York